Metabolomics of per- and polyfluoroalkyl substances (PFAS) exposure: Advances in LC-MS technology and applications
Journal of Food and Drug Analysis · 06.07.2026 · 34 (1)
DOI: 10.38212/2224-6614.3575 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Food and Drug Analysis, online erschienen am 06.07.2026. Verfasst von Yu-Meng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Metabolomics, Fluorocarbons, Liquid Chromatography-Mass Spectrometry, Environmental Pollutants. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic chemicals known for their high stability and bioaccumulation potential, leading to their widespread presence in the environment and human tissues. Exposure to PFAS has been associated with significant health concerns, including neurotoxicity, hepatotoxicity, and metabolic disturbances. Liquid chromatography–mass spectrometry (LC-MS) based metabolomics has emerged as a powerful and central tool for PFAS research, enabling the comprehensive analysis of metabolic changes induced by exposure. This review provides a critical summary of the applications of LC-MS metabolomics in both clinical studies and various experimental models, including in vivo models (mice) and in vitro systems (cell cultures and zebrafish embryos). We highlight key findings from these studies, specifically focusing on the identification of altered metabolic pathways (e.g., lipid, amino acid, and purine metabolism) and the discovery of specific metabolic biomarkers. Furthermore, we explore the intricate interconnections among these metabolic perturbations, which collectively provide a clearer picture of PFAS toxicological effects. By integrating systematic experimental design with advanced LCMS techniques, PFAS metabolomics offers invaluable insights into the molecular-level responses to exposure, helping to elucidate toxicological mechanisms and identify specific metabolic biomarkers. The findings synthesized in this review are crucial for supporting a more standardized approach to risk assessment and for informing evidence-based public health policies related to PFAS monitoring and regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Chemistry, National Taiwan Normal University, Taipei, Taiwan.
- Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.
Zitieren
APA
Wang, Y. M., Lin, P. C., Zheng, Y. D., Wu, P. S., Hua, K. T., & Chen, S. F. (2026). Metabolomics of per- and polyfluoroalkyl substances (PFAS) exposure: Advances in LC-MS technology and applications. Journal of Food and Drug Analysis, 34(1). https://doi.org/10.38212/2224-6614.3575
Vancouver
Wang YM, Lin PC, Zheng YD, Wu PS, Hua KT, Chen SF. Metabolomics of per- and polyfluoroalkyl substances (PFAS) exposure: Advances in LC-MS technology and applications. Journal of Food and Drug Analysis. 2026;34(1). doi:10.38212/2224-6614.3575
BibTeX
@article{Wang2026,
author = {Wang, Yu-Meng and Lin, Pei-Chen and Zheng, Yu-Da and Wu, Pin-Shiuan and Hua, Kuo-Tai and Chen, Sung-Fang},
title = {Metabolomics of per- and polyfluoroalkyl substances (PFAS) exposure: Advances in LC-MS technology and applications},
journal = {Journal of Food and Drug Analysis},
year = {2026},
volume = {34},
number = {1},
doi = {10.38212/2224-6614.3575}
}
EUVIMED